HPR111 Disease Burden and Medical Insurance Expenditure of National Price-Negotiated Drugs for Multiple Sclerosis Under Dual-Channel Model in China: A Budget Impact Model
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.1180
https://www.valueinhealthjournal.com/article/S1098-3015(24)01295-6/fulltext
Title :
HPR111 Disease Burden and Medical Insurance Expenditure of National Price-Negotiated Drugs for Multiple Sclerosis Under Dual-Channel Model in China: A Budget Impact Model
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01295-6&doi=10.1016/j.jval.2024.03.1180
First page :
Section Title :
Open access? :
No
Section Order :
10596